Tags : KRAS

KRAS-targeted Drugs R&D Service

KRAS-targeted Drugs R&D Service

A Story by Medicilon


RAS is one of the most frequently mutated oncogenes in human cancer. KRAS is the isoform most frequently mutated, which constitutes about 85% of RAS m..